New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
The proposal seeks to move any future LDT authority away from the FDA
From – G2 Compliance Advisor
There are many benefits laboratories can’t provide to beneficiaries or referral sources without running afoul of the Anti-Kickback Statute. New changes to safe harbor regulations, however…
From – Diagnostic Testing & Emerging Technologies
In mid-July, the Senate Finance Committee heard testimony from stakeholders arguing for changes to the Stark Law that could make compliance easier and…